Dianthus Therapeutics, Inc. · NASDAQ:DNTH
Veness Adam M sold 30,000 Dianthus Therapeutics, Inc. shares (Form 4)
Traded Jun 17, 2026 · Filed Jun 18, 2026
On Jun 17, 2026, Veness Adam M (SVP, General Counsel and Sec.) sold 30,000 Dianthus Therapeutics, Inc. shares at an average US$80.80 for US$2.42M under a trading plan, leaving 0 shares. Filed Jun 18, 2026 (Form 4).
- Sold
- 30,000 shares
- Price
- US$80.80 average (US$80.34 to US$81.38)
- Value
- US$2.42M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, General Counsel and Sec.
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | Option exercise | 30,000 | US$17.88 | 30,000 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 16,771 | US$80.34 | 13,229 | Direct |
| Jun 17, 2026 | Common Stock | Sale | 13,229 | US$81.38 | 0 | Direct |
Source
Related
- Dianthus Therapeutics, Inc.
- Veness Adam M
- Dianthus Therapeutics, Inc. shareholders
- Form 4 · Veness Adam M · Aug 14, 2026
- Form 4 · Veness Adam M · Aug 11, 2026
- Form 4 · Carr Edward · Sep 18, 2026
- Form 4 · Randhawa Simrat · Sep 3, 2026
- Form 4 · Read Simon · Aug 19, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · Wellington Management Group LLP · Aug 13, 2026